Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phenylacetic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111807990A reveals a one-pot method for trifloxystrobin intermediates. Achieve high purity and cost reduction in agrochemical manufacturing with scalable processes.
Patent CN104086392A reveals a water-based Suzuki coupling for Felbinac. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104693019B reveals a safer route for 2 5-dibromo phenylacetic acid. Achieve high purity and cost reduction in pharma intermediates manufacturing with scalable methods.
Novel Aeromonas caviae B18 strain enables high-purity chiral intermediate production with reduced costs and simplified downstream processing for pharma.
Patent CN108191633A reveals a novel homoanisic acid synthesis route offering high purity and yield. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1235856C reveals a novel carbonylation route for phenylacetic acid derivatives, offering significant cost reduction and purity improvements for API manufacturing.
Explore CN1087337A technology for leukotriene inhibitors. We offer reliable pharmaceutical intermediates supplier services with optimized etherification and alkylation routes.
Patent CN110305010A details a green Grignard route for 2 5-dimethylphenylacetic acid. This method eliminates toxic cyanide and noble metals, ensuring cost reduction and supply reliability.
Novel two-step synthesis for Repaglinide intermediate offering high purity, recyclable solvents, and significant cost reduction in API manufacturing.
Patent CN111718290B reveals a one-step synthesis for isoindoline-1-carboxylic acid derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN119638597B reveals optimized synthesis reducing salt and solvent. Enhances supply chain reliability for agrochemical intermediate manufacturing globally.
Patent CN101538542B reveals a novel Pseudomonas esterase for high-purity mandelic acid. This biocatalytic route offers significant cost reduction and supply chain reliability for chiral intermediates.
Patent CN1377337A details a novel route for COX-2 inhibitor intermediates via lactam hydrolysis. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Novel synthesis route for Baculiferin L intermediate. Cost-effective, scalable, high-purity pharmaceutical intermediate manufacturing process.
Patent CN114380682A reveals a novel low-toxicity synthesis route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN109320413A reveals a mixed catalyst system for phenylacetic acid. This method ensures high purity and safer manufacturing for global supply chains.
Patent CN115417793A reveals a streamlined route for (E)-2-methyl-α-methoxyiminophenylacetic acid methyl ester, offering significant cost and purity advantages.
Patent CN109665999B details a novel U-type template strategy for meta-selective C-H activation, offering cost reduction in API manufacturing and scalable routes for high-purity intermediates.
Novel industrial route for 2,4,5-trifluorophenylacetic acid using 2,4-dichlorotoluene. High yield, cost-effective manufacturing for DPP-4 inhibitor intermediates.
Patent CN110305010B details a high-yield Grignard carboxylation route for 2,5-dimethylphenylacetic acid, eliminating toxic cyanides and noble metal catalysts for cost-effective manufacturing.